Results 191 to 200 of about 18,251 (231)

Bone Mineral Density After Transitioning From Denosumab to Alendronate

Journal of Clinical Endocrinology and Metabolism, 2020
David L Kendler, Patricia Clark, Peter R Ebeling   +2 more
exaly  

Alendronate

2011
openaire   +2 more sources

II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women

Endocrine Reviews, 2002
Ann Cranney, Nicole Zytaruk, Vivian Robinson   +2 more
exaly  

Alendronate

2007
openaire   +1 more source

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Lancet, The, 1996
Dennis M Black, Steven R Cummings, Jane A Cauley   +2 more
exaly  

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

Journal of Bone and Mineral Research, 2007
Sophie A Jamal, Douglas C Bauer, Kristine E Ensrud   +2 more
exaly  

Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension

Journal of Bone and Mineral Research, 2004
Douglas C Bauer, Adrianne Feldstein, Antonio Lombardi   +2 more
exaly  

Alendronate

2017
openaire   +2 more sources

Strengthening the potential of biomineralized microspheres in enhancing osteogenesis via incorporating alendronate

Chemical Engineering Journal, 2019
Zuoying Yuan, Yiqian Huang, Qing Cai
exaly  

Clinical pharmacology of alendronate sodium

Osteoporosis International, 1993
B J Gertz, B K Matuszewski, Arturo G Porras   +2 more
exaly